Merriman Curhan Ford
-
Exclusive: Sanofi considers job cuts as CEO seeks to reduce costs - sources
-
European shares boosted by earnings, progress on coronavirus treatment
-
UK bribery investigation adds to Glencore's legal headaches
-
Stada, buyout funds in race for Bristol-Myers' French business: sources
-
GlaxoSmithKline appoints HSBC's Iain Mackay as new CFO
-
More drugmakers build Brexit stockpiles as EU agency faces exodus
-
British ministers want post-Brexit drug regulation deal with EU
-
BP cuts CEO's pay package after shareholder backlash
-
Britain fines Pfizer record $107 million for huge drug price hike
-
AstraZeneca sees big healthcare changes under Trump
-
Unusual 11 Mid-Day Movers 2/18: MIPI, ZNT, TXCC, INTT, NMTI Higher; XNPT, CSCX, DEPO, TRMA Lower
-
Unusual 11 Mid-Day Movers 11/16: SPEX, NLST, DRAM, XJT Higher; PARD, CRXX, CAEI, CHIO Lower
-
Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded
-
Morning Movers 11/16: SPEX, NLST, XJT, NABI, KHD, IBKC, SPA Higher; PARD, CRXX, CAEI Lower

